After 14 days of drug treatment, the fluorescence intensity of peptide-functionalized gold NPs in the macrophages of mice with lung cancer was stronger (90%) than that of the non-peptide group, and VEGF expression was reduced by 80%, indicating that peptide-functionalized gold NPs could specifically target TAMs and effectively silence VEGF mRNA. Here, VEGFA is linked to lung cancer.